Results 1 to 10 of about 4,884 (228)

Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors

open access: yesPathogens, 2023
The worldwide public health and socioeconomic consequences caused by the COVID-19 pandemic highlight the importance of increasing preparedness for viral disease outbreaks by providing rapid disease prevention and treatment strategies.
Marion Schuller   +2 more
exaly   +4 more sources

Structure-Based Rational Design of a Selective Hydrolase Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus-2 Nsp3 Macrodomain. [PDF]

open access: yesChembiochem
Viral macrodomains, which hydrolyze mono‐ADP‐ribosylated proteins to evade host immunity, represent emerging antiviral targets, yet their druggability remains underexplored.
Krishnathas R   +13 more
europepmc   +3 more sources

Recurrent Loss of Macrodomain Activity in Host Immunity and Viral Proteins

open access: yesPathogens, 2023
Protein post-translational modifications (PTMs) are an important battleground in the evolutionary arms races that are waged between the host innate immune system and viruses.
Sofia Elena Delgado-Rodriguez   +2 more
exaly   +4 more sources

Legionella metaeffector MavL reverses ubiquitin ADP-ribosylation via a conserved arginine-specific macrodomain [PDF]

open access: yesNature Communications
ADP-ribosylation is a reversible post-translational modification involved in various cellular activities. Removal of ADP-ribosylation requires (ADP-ribosyl)hydrolases, with macrodomain enzymes being a major family in this category.
Zhengrui Zhang   +8 more
doaj   +3 more sources

Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge [PDF]

open access: yesJournal of Virology
Infectious bronchitis virus (IBV) is the etiological agent of infectious bronchitis, an acute highly contagious economically important disease of chickens.
Sarah Keep   +12 more
doaj   +3 more sources

Screening assay to monitor mono-ADP-ribosylhydrolase activity of viral macrodomains in cells [PDF]

open access: yesCommunications Biology
Mono-ADP-ribosylation, a modification of both proteins and nucleic acids, is implicated in innate immunity. Intracellularly, this modification is catalyzed by PARP enzymes, some induced in response to interferons.
Sarah Knapp   +16 more
doaj   +2 more sources

Targeting SARS-CoV-2 Macrodomain-1 to Restore the Innate Immune Response Using In Silico Screening of Medicinal Compounds and Free Energy Calculation Approaches

open access: yesViruses, 2023
Among the different drug targets of SARS-CoV-2, a multi-domain protein known as NSP3 is a critical element of the translational and replication machinery.
Anwar Mohammad   +7 more
doaj   +2 more sources

The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses

open access: yesPathogens, 2022
Emerging and re-emerging viral diseases pose continuous public health threats, and effective control requires a combination of non-pharmacologic interventions, treatment with antivirals, and prevention with vaccines.
Anthony K. L. Leung   +3 more
doaj   +2 more sources

The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling

open access: yesJournal of Biological Chemistry, 2021
SARS-CoV-2 non-structural protein 3 (Nsp3) contains a macrodomain that is essential for virus replication and is thus an attractive target for drug development.
Lilian Cristina Russo   +2 more
exaly   +2 more sources

The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection

open access: yesMBio, 2016
ADP-ribosylation is a common posttranslational modification that may have antiviral properties and impact innate immunity. To regulate this activity, macrodomain proteins enzymatically remove covalently attached ADP-ribose from protein targets.
Anthony R Fehr   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy